Level of HER2/neu gene amplification as a predictive factor of response to trastuzumab-based therapy in patients with HER2-positive metastatic breast ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2009-04

AUTHORS

Giuseppe Gullo, Daniela Bettio, Valter Torri, Giovanna Masci, Piermario Salvini, Armando Santoro

ABSTRACT

To explore the clinical significance of the level of HER2/neu gene amplification in a homogenous cohort of 33 patients with HER2-positive metastatic breast cancer (MBC) and available tumor samples treated with a trastuzumab-based regimen, we retrospectively performed dual-color fluorescence in-situ hybridization test and correlated them for each patient with time-to-progression (TTP) and overall survival (OS). We obtained values of HER2/chromosome 17 centromere (CEP17) ratio ranging from 2.5 to 21 (median 7.2). At the Cox model there is indication that patients whose tumors have high-level HER2/CEP17 ratio have shorter TTP and OS than those with lower ratio, when treated with a trastuzumab-based regimen. Correlations do not reach the limits of statistical significance but no formal sample size calculation was performed due to the explorative nature of the study. If confirmed in larger cohorts of patients, HER2/CEP17 ratio could represent a reliable and economical predictor of response to trastuzumab-based therapy in MBC. More... »

PAGES

179

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10637-008-9155-y

DOI

http://dx.doi.org/10.1007/s10637-008-9155-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1016696899

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18663410


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Humanized", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Amplification", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genes, erbB-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Situ Hybridization, Fluorescence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Predictive Value of Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Trastuzumab", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Humanitas Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417728.f", 
          "name": [
            "Oncology and Hematology Unit, Istituto Clinico Humanitas IRCCS, Via Manzoni 56, Rozzano, (Milan), Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gullo", 
        "givenName": "Giuseppe", 
        "id": "sg:person.01223342332.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223342332.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Humanitas Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417728.f", 
          "name": [
            "Laboratory of Cytogenetics, Istituto Clinico Humanitas IRCCS, Rozzano, (Milan), Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bettio", 
        "givenName": "Daniela", 
        "id": "sg:person.0726433703.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726433703.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mario Negri Institute for Pharmacological Research", 
          "id": "https://www.grid.ac/institutes/grid.4527.4", 
          "name": [
            "Clinical Oncology Research Unit, Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Torri", 
        "givenName": "Valter", 
        "id": "sg:person.01213013520.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213013520.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Humanitas Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417728.f", 
          "name": [
            "Oncology and Hematology Unit, Istituto Clinico Humanitas IRCCS, Via Manzoni 56, Rozzano, (Milan), Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Masci", 
        "givenName": "Giovanna", 
        "id": "sg:person.01203725612.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203725612.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Medical Oncology Unit, Cliniche Gavazzeni, Bergamo, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salvini", 
        "givenName": "Piermario", 
        "id": "sg:person.01357677760.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357677760.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Humanitas Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417728.f", 
          "name": [
            "Oncology and Hematology Unit, Istituto Clinico Humanitas IRCCS, Via Manzoni 56, Rozzano, (Milan), Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Santoro", 
        "givenName": "Armando", 
        "id": "sg:person.01277354144.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277354144.26"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.3816/cbc.2005.n.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001198940"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.04.173", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003035955"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3816/cbc.2001.n.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003466394"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.copbio.2007.11.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007493316"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602926", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012929330", 
          "https://doi.org/10.1038/sj.bjc.6602926"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602926", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012929330", 
          "https://doi.org/10.1038/sj.bjc.6602926"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.14.8957", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019255637"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2006.11.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022644824"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.2775", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026719751"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdj905", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031702252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm200103153441101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031768583"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ccr.2007.08.030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034133737"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1006111117877", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037590396", 
          "https://doi.org/10.1023/a:1006111117877"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1097/01.mp.0000052102.90815.82", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043809974", 
          "https://doi.org/10.1097/01.mp.0000052102.90815.82"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdl475", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046368550"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djk134", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047572985"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djk134", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047572985"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1006262324959", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047763314", 
          "https://doi.org/10.1023/a:1006262324959"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049278910"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-06-1304", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049548242"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.3798106", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062621480"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.20.3.719", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064202789"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2002.20.3.719", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083941918"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-04", 
    "datePublishedReg": "2009-04-01", 
    "description": "To explore the clinical significance of the level of HER2/neu gene amplification in a homogenous cohort of 33 patients with HER2-positive metastatic breast cancer (MBC) and available tumor samples treated with a trastuzumab-based regimen, we retrospectively performed dual-color fluorescence in-situ hybridization test and correlated them for each patient with time-to-progression (TTP) and overall survival (OS). We obtained values of HER2/chromosome 17 centromere (CEP17) ratio ranging from 2.5 to 21 (median 7.2). At the Cox model there is indication that patients whose tumors have high-level HER2/CEP17 ratio have shorter TTP and OS than those with lower ratio, when treated with a trastuzumab-based regimen. Correlations do not reach the limits of statistical significance but no formal sample size calculation was performed due to the explorative nature of the study. If confirmed in larger cohorts of patients, HER2/CEP17 ratio could represent a reliable and economical predictor of response to trastuzumab-based therapy in MBC.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10637-008-9155-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1094201", 
        "issn": [
          "0167-6997", 
          "1573-0646"
        ], 
        "name": "Investigational New Drugs", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "27"
      }
    ], 
    "name": "Level of HER2/neu gene amplification as a predictive factor of response to trastuzumab-based therapy in patients with HER2-positive metastatic breast cancer", 
    "pagination": "179", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10637-008-9155-y"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "4f8dd6d38b5348ae802a862450e05f0418acb3e4f2fc9d4658c21e7bd7bcaad5"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1016696899"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309330"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18663410"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10637-008-9155-y", 
      "https://app.dimensions.ai/details/publication/pub.1016696899"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-15T09:13", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000376_0000000376/records_56164_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs10637-008-9155-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10637-008-9155-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10637-008-9155-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10637-008-9155-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10637-008-9155-y'


 

This table displays all metadata directly associated to this object as RDF triples.

241 TRIPLES      21 PREDICATES      66 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10637-008-9155-y schema:about N0977f5086380441699a694343efd0348
2 N1b7bac8b0d8643debac8d9a87f18df97
3 N4e137eadbdd74bdeb49d7dc2ab55cc61
4 N60b3c5bb895a455cb9705116451fc97e
5 N60df798cebed4333adcd9f9b9be5f49f
6 N624bc88e498f43fdbf750c1beb042abd
7 N6f4348b6605148e3b011f9a11618f177
8 N70ea8a852b204949b9039e5278d105e1
9 N81376e691ced427a8c3099652690e7e5
10 N896f80b2071e4a23b4273358416674a0
11 N98657bc30bcd4a17b294e8118e774f62
12 Na130f1a87a0248a187bf61aa0df3f642
13 Na4d88740822041ab9a40b0450ca2b78c
14 Nce02eb4b163d4c26a7b1afede76a42c3
15 Nde32c42a985d4aeb82c13a9cc90069b0
16 Ne37fe5e66bd145b0a16d932a0f14cdf3
17 anzsrc-for:11
18 anzsrc-for:1112
19 schema:author N294a1c7458db4d3ea319376583b20b37
20 schema:citation sg:pub.10.1023/a:1006111117877
21 sg:pub.10.1023/a:1006262324959
22 sg:pub.10.1038/sj.bjc.6602926
23 sg:pub.10.1097/01.mp.0000052102.90815.82
24 https://doi.org/10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6
25 https://doi.org/10.1016/j.ccr.2007.08.030
26 https://doi.org/10.1016/j.copbio.2007.11.004
27 https://doi.org/10.1016/j.ejca.2006.11.019
28 https://doi.org/10.1056/nejm200103153441101
29 https://doi.org/10.1093/annonc/mdj905
30 https://doi.org/10.1093/annonc/mdl475
31 https://doi.org/10.1093/jnci/djk134
32 https://doi.org/10.1126/science.3798106
33 https://doi.org/10.1158/1078-0432.ccr-06-1304
34 https://doi.org/10.1200/jco.20.3.719
35 https://doi.org/10.1200/jco.2002.20.3.719
36 https://doi.org/10.1200/jco.2005.04.173
37 https://doi.org/10.1200/jco.2006.09.2775
38 https://doi.org/10.1200/jco.2007.14.8957
39 https://doi.org/10.3816/cbc.2001.n.017
40 https://doi.org/10.3816/cbc.2005.n.026
41 schema:datePublished 2009-04
42 schema:datePublishedReg 2009-04-01
43 schema:description To explore the clinical significance of the level of HER2/neu gene amplification in a homogenous cohort of 33 patients with HER2-positive metastatic breast cancer (MBC) and available tumor samples treated with a trastuzumab-based regimen, we retrospectively performed dual-color fluorescence in-situ hybridization test and correlated them for each patient with time-to-progression (TTP) and overall survival (OS). We obtained values of HER2/chromosome 17 centromere (CEP17) ratio ranging from 2.5 to 21 (median 7.2). At the Cox model there is indication that patients whose tumors have high-level HER2/CEP17 ratio have shorter TTP and OS than those with lower ratio, when treated with a trastuzumab-based regimen. Correlations do not reach the limits of statistical significance but no formal sample size calculation was performed due to the explorative nature of the study. If confirmed in larger cohorts of patients, HER2/CEP17 ratio could represent a reliable and economical predictor of response to trastuzumab-based therapy in MBC.
44 schema:genre research_article
45 schema:inLanguage en
46 schema:isAccessibleForFree true
47 schema:isPartOf N1af7d1fd6e24425d8502ac9a2485e19c
48 N6549910bee2547a4b1b8d98668e82991
49 sg:journal.1094201
50 schema:name Level of HER2/neu gene amplification as a predictive factor of response to trastuzumab-based therapy in patients with HER2-positive metastatic breast cancer
51 schema:pagination 179
52 schema:productId N35e7a71feb6e4c36939aa0a5b8a388ea
53 N82f0b339adf94876a8f46e78670e4a08
54 Nbb98600aff364fab9baa8fa7da6de94b
55 Nc9e227223c4f4ec798fa19affe91bd9f
56 Nd3cf6772e8cd474db7ea809e04a10404
57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016696899
58 https://doi.org/10.1007/s10637-008-9155-y
59 schema:sdDatePublished 2019-04-15T09:13
60 schema:sdLicense https://scigraph.springernature.com/explorer/license/
61 schema:sdPublisher N5c05f780ec814d48a8b2adc49560da74
62 schema:url https://link.springer.com/10.1007%2Fs10637-008-9155-y
63 sgo:license sg:explorer/license/
64 sgo:sdDataset articles
65 rdf:type schema:ScholarlyArticle
66 N029080680e334d03804f23e6ab529ac7 rdf:first sg:person.01357677760.43
67 rdf:rest N4429ba2815ee4e8d81beac026b130922
68 N0977f5086380441699a694343efd0348 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Genes, erbB-2
70 rdf:type schema:DefinedTerm
71 N19aae64822f747a4892cfcec1bb1ab4a rdf:first sg:person.01203725612.04
72 rdf:rest N029080680e334d03804f23e6ab529ac7
73 N1af7d1fd6e24425d8502ac9a2485e19c schema:volumeNumber 27
74 rdf:type schema:PublicationVolume
75 N1b7bac8b0d8643debac8d9a87f18df97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Trastuzumab
77 rdf:type schema:DefinedTerm
78 N294a1c7458db4d3ea319376583b20b37 rdf:first sg:person.01223342332.02
79 rdf:rest N5c73999ba4c747c7b19c68bbfa66bba0
80 N35e7a71feb6e4c36939aa0a5b8a388ea schema:name pubmed_id
81 schema:value 18663410
82 rdf:type schema:PropertyValue
83 N4429ba2815ee4e8d81beac026b130922 rdf:first sg:person.01277354144.26
84 rdf:rest rdf:nil
85 N4e137eadbdd74bdeb49d7dc2ab55cc61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Retrospective Studies
87 rdf:type schema:DefinedTerm
88 N5c05f780ec814d48a8b2adc49560da74 schema:name Springer Nature - SN SciGraph project
89 rdf:type schema:Organization
90 N5c73999ba4c747c7b19c68bbfa66bba0 rdf:first sg:person.0726433703.81
91 rdf:rest Ne16cc1f940244c259b019ca84a5fb83e
92 N60b3c5bb895a455cb9705116451fc97e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Gene Amplification
94 rdf:type schema:DefinedTerm
95 N60df798cebed4333adcd9f9b9be5f49f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Breast Neoplasms
97 rdf:type schema:DefinedTerm
98 N624bc88e498f43fdbf750c1beb042abd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Predictive Value of Tests
100 rdf:type schema:DefinedTerm
101 N6549910bee2547a4b1b8d98668e82991 schema:issueNumber 2
102 rdf:type schema:PublicationIssue
103 N69c3f8c630af4686b68a0825194b6b35 schema:name Medical Oncology Unit, Cliniche Gavazzeni, Bergamo, Italy
104 rdf:type schema:Organization
105 N6f4348b6605148e3b011f9a11618f177 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Adult
107 rdf:type schema:DefinedTerm
108 N70ea8a852b204949b9039e5278d105e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Aged
110 rdf:type schema:DefinedTerm
111 N81376e691ced427a8c3099652690e7e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Disease-Free Survival
113 rdf:type schema:DefinedTerm
114 N82f0b339adf94876a8f46e78670e4a08 schema:name doi
115 schema:value 10.1007/s10637-008-9155-y
116 rdf:type schema:PropertyValue
117 N896f80b2071e4a23b4273358416674a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Humans
119 rdf:type schema:DefinedTerm
120 N98657bc30bcd4a17b294e8118e774f62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Middle Aged
122 rdf:type schema:DefinedTerm
123 Na130f1a87a0248a187bf61aa0df3f642 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Antineoplastic Agents
125 rdf:type schema:DefinedTerm
126 Na4d88740822041ab9a40b0450ca2b78c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name In Situ Hybridization, Fluorescence
128 rdf:type schema:DefinedTerm
129 Nbb98600aff364fab9baa8fa7da6de94b schema:name dimensions_id
130 schema:value pub.1016696899
131 rdf:type schema:PropertyValue
132 Nc9e227223c4f4ec798fa19affe91bd9f schema:name readcube_id
133 schema:value 4f8dd6d38b5348ae802a862450e05f0418acb3e4f2fc9d4658c21e7bd7bcaad5
134 rdf:type schema:PropertyValue
135 Nce02eb4b163d4c26a7b1afede76a42c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Female
137 rdf:type schema:DefinedTerm
138 Nd3cf6772e8cd474db7ea809e04a10404 schema:name nlm_unique_id
139 schema:value 8309330
140 rdf:type schema:PropertyValue
141 Nde32c42a985d4aeb82c13a9cc90069b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Antibodies, Monoclonal, Humanized
143 rdf:type schema:DefinedTerm
144 Ne16cc1f940244c259b019ca84a5fb83e rdf:first sg:person.01213013520.94
145 rdf:rest N19aae64822f747a4892cfcec1bb1ab4a
146 Ne37fe5e66bd145b0a16d932a0f14cdf3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Antibodies, Monoclonal
148 rdf:type schema:DefinedTerm
149 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
150 schema:name Medical and Health Sciences
151 rdf:type schema:DefinedTerm
152 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
153 schema:name Oncology and Carcinogenesis
154 rdf:type schema:DefinedTerm
155 sg:journal.1094201 schema:issn 0167-6997
156 1573-0646
157 schema:name Investigational New Drugs
158 rdf:type schema:Periodical
159 sg:person.01203725612.04 schema:affiliation https://www.grid.ac/institutes/grid.417728.f
160 schema:familyName Masci
161 schema:givenName Giovanna
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203725612.04
163 rdf:type schema:Person
164 sg:person.01213013520.94 schema:affiliation https://www.grid.ac/institutes/grid.4527.4
165 schema:familyName Torri
166 schema:givenName Valter
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213013520.94
168 rdf:type schema:Person
169 sg:person.01223342332.02 schema:affiliation https://www.grid.ac/institutes/grid.417728.f
170 schema:familyName Gullo
171 schema:givenName Giuseppe
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223342332.02
173 rdf:type schema:Person
174 sg:person.01277354144.26 schema:affiliation https://www.grid.ac/institutes/grid.417728.f
175 schema:familyName Santoro
176 schema:givenName Armando
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277354144.26
178 rdf:type schema:Person
179 sg:person.01357677760.43 schema:affiliation N69c3f8c630af4686b68a0825194b6b35
180 schema:familyName Salvini
181 schema:givenName Piermario
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357677760.43
183 rdf:type schema:Person
184 sg:person.0726433703.81 schema:affiliation https://www.grid.ac/institutes/grid.417728.f
185 schema:familyName Bettio
186 schema:givenName Daniela
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726433703.81
188 rdf:type schema:Person
189 sg:pub.10.1023/a:1006111117877 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037590396
190 https://doi.org/10.1023/a:1006111117877
191 rdf:type schema:CreativeWork
192 sg:pub.10.1023/a:1006262324959 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047763314
193 https://doi.org/10.1023/a:1006262324959
194 rdf:type schema:CreativeWork
195 sg:pub.10.1038/sj.bjc.6602926 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012929330
196 https://doi.org/10.1038/sj.bjc.6602926
197 rdf:type schema:CreativeWork
198 sg:pub.10.1097/01.mp.0000052102.90815.82 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043809974
199 https://doi.org/10.1097/01.mp.0000052102.90815.82
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049278910
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1016/j.ccr.2007.08.030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034133737
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1016/j.copbio.2007.11.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007493316
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1016/j.ejca.2006.11.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022644824
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1056/nejm200103153441101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031768583
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1093/annonc/mdj905 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031702252
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1093/annonc/mdl475 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046368550
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1093/jnci/djk134 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047572985
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1126/science.3798106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062621480
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1158/1078-0432.ccr-06-1304 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049548242
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1200/jco.20.3.719 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064202789
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1200/jco.2002.20.3.719 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083941918
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1200/jco.2005.04.173 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003035955
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1200/jco.2006.09.2775 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026719751
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1200/jco.2007.14.8957 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019255637
230 rdf:type schema:CreativeWork
231 https://doi.org/10.3816/cbc.2001.n.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003466394
232 rdf:type schema:CreativeWork
233 https://doi.org/10.3816/cbc.2005.n.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001198940
234 rdf:type schema:CreativeWork
235 https://www.grid.ac/institutes/grid.417728.f schema:alternateName Humanitas Research Hospital
236 schema:name Laboratory of Cytogenetics, Istituto Clinico Humanitas IRCCS, Rozzano, (Milan), Italy
237 Oncology and Hematology Unit, Istituto Clinico Humanitas IRCCS, Via Manzoni 56, Rozzano, (Milan), Italy
238 rdf:type schema:Organization
239 https://www.grid.ac/institutes/grid.4527.4 schema:alternateName Mario Negri Institute for Pharmacological Research
240 schema:name Clinical Oncology Research Unit, Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
241 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...